<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Am J Transplant</span><span class="iso-abbrev" title="iso-abbrev">Am. J. Transplant</span><span class="doi" title="doi">10.1111/(ISSN)1600-6143</span><span class="publisher-id" title="publisher-id">AJT</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">American Journal of Transplantation</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1600-6135</span><span class="issn-epub" tagx="issn" title="issn-epub">1600-6143</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">John Wiley and Sons Inc.</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Hoboken</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7436557">7436557</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1111/ajt.16250">10.1111/ajt.16250</a></span><span class="publisher-id" title="publisher-id">AJT16250</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Minireview</span>: <span class="subject" title="subject">Minireviews</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Cyclosporine and COVIDâ€�19: Risk or Favorable?</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Poulsen</span><span class="given-names" tagx="given-names" title="given-names">Nadia Nicholine</span></span><a href="#ajt16250-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">von Brunn</span><span class="given-names" tagx="given-names" title="given-names">Albrecht</span></span><a href="#ajt16250-aff-0002"><sup>2</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hornum</span><span class="given-names" tagx="given-names" title="given-names">Mads</span></span><a href="#ajt16250-aff-0003"><sup>3</sup></a><a href="#ajt16250-aff-0004"><sup>4</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Blomberg Jensen</span><span class="given-names" tagx="given-names" title="given-names">Martin</span></span><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-3800-4253</span><a href="#ajt16250-aff-0001"><sup>1</sup></a><a href="#ajt16250-aff-0005"><sup>5</sup></a><span class="address" title="address"><span class="email" tagx="email" title="email">blombergjensen@gmail.com</span></span></span></div><span class="citation_author_institution" id="ajt16250-aff-0001">[1], <span class="institution" title="institution">Group of Skeletal, Mineral, and Gonadal Endocrinology</span><span class="institution" title="institution">Department of Growth and Reproduction, Rigshospitalet</span><span class="city" tagx="city" title="city">Copenhagen</span><span class="country" tagx="country" title="country">Denmark</span></span><span class="citation_author_institution" id="ajt16250-aff-0002">[2], <span class="institution" title="institution">Max von Pettenkoferâ€�Institute</span><span class="institution" title="institution">Ludwigâ€�Maximiliansâ€�University Munich</span><span class="named-content" title="named-content">German Center for Infection Research (DZIF)</span><span class="named-content" title="named-content">Partner Site Munich</span><span class="postal-code" tagx="postal-code" title="postal-code">80336</span><span class="city" tagx="city" title="city">Munich</span><span class="country" tagx="country" title="country">Germany</span></span><span class="citation_author_institution" id="ajt16250-aff-0003">[3], <span class="institution" title="institution">Department of Nephrology, Rigshospitalet</span><span class="city" tagx="city" title="city">Copenhagen</span><span class="country" tagx="country" title="country">Denmark</span></span><span class="citation_author_institution" id="ajt16250-aff-0004">[4], <span class="named-content" title="named-content">Department of Clinical Medicine</span><span class="named-content" title="named-content">Faculty of Health and Medical Sciences</span><span class="institution" title="institution">University of Copenhagen</span><span class="city" tagx="city" title="city">Copenhagen</span><span class="country" tagx="country" title="country">Denmark</span></span><span class="citation_author_institution" id="ajt16250-aff-0005">[5], <span class="named-content" title="named-content">Division of Bone and Mineral Research</span><span class="institution" title="institution">HSDM/HMS Harvard University</span><span class="city" tagx="city" title="city">Boston</span><span class="named-content" title="named-content">MA</span><span class="country" tagx="country" title="country">USA</span></span><div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">*</span> Corresponding author<br /><br /> Martin Blomberg Jensen<br /><br /> Email: <span class="email" tagx="email" title="email">blombergjensen@gmail.com</span><br /><br /></div> </div><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-8-8</span></span><span class="elocation-id" tagx="elocation-id" title="elocation-id">10.1111/ajt.16250</span><div class="permissions"><span class="copyright" title="copyright">(C) , </span><span class="license" title="license"><span class="license-p" title="license-p">This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</span></span></div><a class="self-uri" href="file:AJT-9999-na.pdf" title="self-uri">file:AJT-9999-na.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>The coronavirus disease 2019 (COVIDâ€�19) pandemic is declared a global health emergency. COVIDâ€�19 is triggered by a novel coronavirus: Severe Acute Respiratory Syndrome Coronavirus 2 (SARSâ€�CoV2). Baseline characteristics of admitted patients with COVIDâ€�19 show that adiposity, diabetes and hypertension are risk factors for developing severe disease, but so far immunosuppressed patients that are listed as highâ€�risk patients have not been more susceptible to severe COVIDâ€�19 than the rest of the population. Multiple clinical trials are currently being conducted, which hopefully can identify more drugs that can lower mortality, morbidity and burden on the society. Several independent studies have convincingly shown that cyclosporine inhibit replication of several different coronaviruses <i>in vitro</i>. The cyclosporineâ€�analog Alisporivir has recently been shown to inhibit SARSâ€�CoV2 <i>in vitro</i>. These findings are intriguing, although there is no clinical evidence for a protective effect to reduce the likelihood of severe COVIDâ€�19 or to treat the immune storm or adult respiratory distress syndrome (ARDS) that often causes severe morbidity. Here, we review the putative link between COVIDâ€�19 and cyclosporine, while we await more robust clinical data.</p> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> <div class="custom-meta-group" title="custom-meta-group"> <meta name="source-schema-version-number" value="2.0" /> <meta name="edited-state" value="accepted-manuscript" /> <meta name="details-of-publishers-convertor" value="Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.7 mode:remove_FC converted:19.08.2020" /> </div> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-" title=""> <p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/ajt.16250</p> </div> </div> </div>  </body></html>